Angela Sheu

Dr. Angela Sheu

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in JACC
Verified
Journal Article
Closed access
SMStefan A. Mann
Stefan A. Mann
MCMaria L. Castro
Maria L. Castro
MOMonique Ohanian
Monique Ohanian
GGGuanglan Guo
Guanglan Guo
PZPoonam Zodgekar
Poonam Zodgekar
DFDiane Fatkin
Diane Fatkin

1 April 2016 in Australian Prescriber
Verified
Journal Article
Open access
ASAngela Sheu
Angela Sheu
TDTerry Diamond
Terry Diamond
Primary osteoporosis is related to bone loss from ageing. Secondary osteoporosis results from

17 March 2022 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
ASAngela Sheu
Angela Sheu
JGJerry R. Greenfield
Jerry R. Greenfield
CWChristopher P. White
Christopher P. White
JCJacqueline R. Center
Jacqueline R. Center

24 April 2018 in Diabetologia
Verified
Journal Article
Open access
PDF file
ASAngela Sheu
Angela Sheu
YCYixian Chan
Yixian Chan
AFAngela Ferguson
Angela Ferguson
MBMohammad B. Bakhtyari
Mohammad B. Bakhtyari
WHWendy Hawke
Wendy Hawke
SLSue Mei Lau
Sue Mei Lau
Numerous adaptations of the maternal immune system are necessary during pregnancy to maintain immunological tolerance to the semi-allogeneic fetus. Several complications of pregnancy have been associated with dysregulation of these adaptive mechanisms. While gestational diabetes mellitus (GDM) has been associated with upregulation of circulating inflammatory factors linked to innate immunity, polarisation of the adaptive immune system has not been extensively characterised in this condition. We aimed to characterise pro- and anti-inflammatory CD4+ (T helper [Th]) T cell subsets in women with GDM vs women without GDM (of similar BMI), during and after pregnancy, and examine the relationship between CD4+ subsets and severity of GDM.

24 November 2022 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
ASAngela Sheu
Angela Sheu
JGJerry R. Greenfield
Jerry R. Greenfield
CWChristopher P. White
Christopher P. White
JCJacqueline R. Center
Jacqueline R. Center

18 May 2024 in Diabetologia
Verified
Journal Article
Open access
PDF file
ASAngela Sheu
Angela Sheu
CWChristopher P. White
Christopher P. White
JCJacqueline R. Center
Jacqueline R. Center
Skeletal fragility is an increasingly recognised, but poorly understood, complication of both type 1 and type 2 diabetes. Fracture risk varies according to skeletal site and diabetes-related characteristics. Post-fracture outcomes, including mortality risk, are worse in those with diabetes, placing these people at significant risk. Each fracture therefore represents a sentinel event that warrants targeted management. However, diabetes is a very heterogeneous condition with complex interactions between multiple co-existing, and highly correlated, factors that preclude a clear assessment of the independent clinical markers and pathophysiological drivers for diabetic osteopathy. Additionally, fracture risk calculators and routinely used clinical bone measurements generally underestimate fracture risk in people with diabetes. In the absence of dedicated prospective studies including detailed bone and metabolic characteristics, optimal management centres around selecting treatments that minimise skeletal and metabolic harm. This review summarises the clinical landscape of diabetic osteopathy and outlines the interplay between metabolic and skeletal health. The underlying pathophysiology of skeletal fragility in diabetes and a rationale for considering a diabetes-based paradigm in assessing and managing diabetic bone disease will be discussed. Graphical Abstract